Constipation-associated factors in outpatients with schizophrenia: A multicenter questionnaire survey.

IF 2 Q3 NEUROSCIENCES Neuropsychopharmacology Reports Pub Date : 2024-09-01 Epub Date: 2024-07-03 DOI:10.1002/npr2.12464
Taro Tazaki, Hiroki Yamada, Ryotaro Sato, Hiroki Ishii, Shutaro Sugita, Haruka Yanagihara, Dan Nakamura, Osamu Takashio, Atsuko Inamoto, Akira Iwanami
{"title":"Constipation-associated factors in outpatients with schizophrenia: A multicenter questionnaire survey.","authors":"Taro Tazaki, Hiroki Yamada, Ryotaro Sato, Hiroki Ishii, Shutaro Sugita, Haruka Yanagihara, Dan Nakamura, Osamu Takashio, Atsuko Inamoto, Akira Iwanami","doi":"10.1002/npr2.12464","DOIUrl":null,"url":null,"abstract":"<p><p>Constipation is a prevalent gastrointestinal disorder that affects people globally, decreasing their quality of life and life expectancy. Individuals with schizophrenia often suffer from constipation, which could be a result of the illness itself or the side effects of psychotropic medications. However, little research has been conducted on factors contributing to constipation in individuals with schizophrenia. To address this issue, we conducted a survey using self-administered questionnaires and medical records to identify factors associated with constipation in psychiatric outpatients. This study included 399 patients with schizophrenia, resulting in a high prevalence of constipation (43.4%). The analysis suggested that female gender, the doses of antiparkinsonian medications, and benzodiazepine sleeping pills may be associated with constipation.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544439/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychopharmacology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/npr2.12464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Constipation is a prevalent gastrointestinal disorder that affects people globally, decreasing their quality of life and life expectancy. Individuals with schizophrenia often suffer from constipation, which could be a result of the illness itself or the side effects of psychotropic medications. However, little research has been conducted on factors contributing to constipation in individuals with schizophrenia. To address this issue, we conducted a survey using self-administered questionnaires and medical records to identify factors associated with constipation in psychiatric outpatients. This study included 399 patients with schizophrenia, resulting in a high prevalence of constipation (43.4%). The analysis suggested that female gender, the doses of antiparkinsonian medications, and benzodiazepine sleeping pills may be associated with constipation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
精神分裂症门诊患者的便秘相关因素:多中心问卷调查
便秘是一种普遍存在的肠胃疾病,影响着全球各地的人们,降低了他们的生活质量和预期寿命。精神分裂症患者经常会出现便秘,这可能是疾病本身或精神药物副作用的结果。然而,有关导致精神分裂症患者便秘的因素的研究却很少。为了解决这个问题,我们使用自制问卷和医疗记录进行了一项调查,以确定精神科门诊患者便秘的相关因素。这项研究包括 399 名精神分裂症患者,结果显示便秘发生率很高(43.4%)。分析表明,女性性别、抗帕金森氏症药物剂量和苯二氮卓安眠药可能与便秘有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neuropsychopharmacology Reports
Neuropsychopharmacology Reports Psychology-Clinical Psychology
CiteScore
3.60
自引率
4.00%
发文量
75
审稿时长
14 weeks
期刊最新文献
Fluoxetine does not influence response to continuous theta burst stimulation in human motor cortex. The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment. Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare guideline. Successful treatment with olanzapine and aripiprazole of a schizophrenic patient who developed priapism after switching from risperidone to paliperidone. Investigation of risk factors associated with the development of depressive symptoms in healthy subjects exposed to long-term stress: A prospective study of the Japanese Antarctic research expedition wintering party.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1